Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03411356 · ClinicalTrials.gov registry record · NA

Intermittent Fasting Versus Daily Caloric Restriction for Weight Loss

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT03411356: Completed NA study, sponsored by University of Colorado, Denver.

NCT03411356 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03411356, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

The primary aim of this study is to is to determine if intermittent fasting (IMF) is an effective dietary strategy for treatment of obesity. A 1 year randomized trial will be used to compare weight loss generated by IMF versus Daily Caloric Restriction (DCR). The targeted weekly energy deficit is designed to be similar (\~30%) and a comprehensive behavioral support program will be provided to both groups. The primary outcome is weight change at the end of the 1 year intervention; follow up measures will also be obtained 6 months after completing the intervention. This study will provide robust data regarding weight loss effectiveness of IMF and will further our understanding of the impact of IMF on energy balance.

Primary Outcome

Body weight will be measured via clinic scale.

Interventions

  • BEHAVIORAL Daily Caloric Restriction (DCR)
  • BEHAVIORAL Intermittent Fasting (IMF)

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2017-12-22
Est. Completion 2023-01-24
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT03411356 record still lists

NCT03411356 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which Daily Caloric Restriction (DCR) is the first listed.

NCT03411356 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03411356 about?

NCT03411356 is a clinical study titled "Intermittent Fasting Versus Daily Caloric Restriction for Weight Loss". The primary aim of this study is to is to determine if intermittent fasting (IMF) is an effective dietary strategy for treatment of obesity. A 1 year randomized trial will be used to compare weight loss generated by IMF versus Daily Caloric Restriction (DCR). The targeted weekly energy deficit is de...

What is the current status of trial NCT03411356?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2017-12-22. Estimated completion is 2023-01-24.

What interventions are being tested in trial NCT03411356?

The interventions under investigation include: Daily Caloric Restriction (DCR) (BEHAVIORAL), Intermittent Fasting (IMF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03411356?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03411356's enrollment target sits among peer trials

165 626th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03411356, the US trial registry maintained by the National Library of Medicine. NCT03411356 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.